The Canadian Competition Authority clears merger in animal healthcare, subject to structural conditions (Elanco / Bayer Animal Health)

Competition Bureau resolves concerns related to Elanco’s acquisition of Bayer Animal Health* The Competition Bureau announced today that it has entered into a consent agreement with Elanco Animal Health Incorporated (Elanco) to address concerns related to the company’s proposed acquisition of Bayer Animal Health (BAH). Elanco has also committed to forego acquiring Bayer AG’s (Bayer) Canadian distribution rights to several poultry

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Canadian Competition Bureau, The Canadian Competition Authority clears merger in animal healthcare, subject to structural conditions (Elanco / Bayer Animal Health), 14 July 2020, e-Competitions Cooperation between National Competition Authorities, Art. N° 96393

Visites 44

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues